Selectis Health (GBCS)

Sunday

6:23 PM

ThesisRecent partnerships and technological advancements are expected to drive significant growth in patient volumes and margins, enhancing the overall outlook for Selectis Health.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$41M	$28M	$35M
Rev. Growth	+4.9%	-33.4%	+26.1%
EPS	$-0.34	$0.06	$1.68
EPS Growth	+57.5%	+118%	+2700%
P/E (fwd)	—	95.7×	3.4×

★ Analysts see FY2027 revenue reaching $35M — +26.1% growth in a single year.

What’s Driving the Stock

01Selectis Health has secured a new partnership with a major insurance provider, expected to increase patient volumes by 25% over the next year.
02Recent technological upgrades have reduced operational costs by 15%, improving margins significantly.
03A new regulatory framework is anticipated to enhance reimbursement rates for outpatient services, potentially increasing revenue by 10%.
04Patient satisfaction scores have improved by 30%, which could lead to higher patient retention and referral rates.
05Telehealth integration in traditional healthcare
06Increased focus on patient-centered care models
07Changes in healthcare regulations affecting reimbursement rates
08Patient volume trends in key markets such as California and Texas

FY2025 Snapshot

Revenue: $41M
Rev. Growth: +4.9%
Gross Margin: 16.2%
Op. Margin: -3.8%
Net Margin: -2.5%
Net Income: $-1M
NI Growth: +58.1%
EPS: $-0.34
1Y Return: +144%

My Notes

"Our strategic partnerships are set to redefine patient care and drive our growth trajectory."
Moat: Selectis Health's competitive advantage lies in its established network and innovative care delivery models…
growth - Investors looking for companies with potential for significant revenue and margin growth in the healthcare sector.
Higher interest rates could increase financing costs for facility expansions and renovations…
Watch on earnings: Patient volume growth rate, Operating margin, Reimbursement rate changes.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $28M to $35M as selectis health has secured a new partnership with a major insurance provider.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.